Psilocybin-assisted therapy for methamphetamine dependence: a case report
Author Information
Author(s): Brett Jonathan, Knock Elizabeth, Watson Kathy, Albert Steven, Siefried Krista J., Guss Jeffrey
Primary Institution: St. Vincent’s Hospital, Sydney, NSW, Australia
Hypothesis
Can psilocybin-assisted psychotherapy effectively treat methamphetamine dependence?
Conclusion
The case suggests that psilocybin-assisted therapy may be a safe and effective approach for treating methamphetamine dependence.
Supporting Evidence
- The participant experienced significant cognitive and emotional shifts after therapy.
- She maintained abstinence from methamphetamine for 3 months following treatment.
- Improvements in mental health, self-esteem, and mindfulness were reported.
Takeaway
This study shows that a person who used methamphetamine every day was able to stop using it and feel better after trying a special therapy with psilocybin, a substance found in certain mushrooms.
Methodology
The study involved a single-arm, open-label clinical trial assessing the feasibility and safety of psilocybin-assisted therapy for methamphetamine dependence, including preparatory and integration psychotherapy sessions.
Limitations
The findings are based on a single case and may not be generalizable to broader populations.
Participant Demographics
The participant was a 36-year-old transwoman with a history of daily methamphetamine use.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website